DNASTAR — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

DNASTAR is a long-established, private bioinformatics software provider with a focus on sequence analysis and molecular biology research tools. The company operates in the Genetics & Genomics and Bioinformatics sectors, offering a suite of desktop software applications like Lasergene that are widely used in academic and biopharma research. As a mature, revenue-generating entity, it faces competition from both large enterprise software providers and newer cloud-based platforms. Its outlook hinges on modernizing its product suite and expanding into adjacent markets like proteomics and long-read sequencing analysis.

Genetics & GenomicsBioinformatics

Technology Platform

Lasergene software suite for DNA/protein sequence analysis, alignment, assembly, visualization, and molecular biology research.

Opportunities

The explosion of genomic data and the expansion of sequencing into clinical and applied markets create demand for user-friendly analysis tools.

Transitioning to a cloud-based subscription model could open new customer segments and provide more predictable revenue.

Integrating analysis for emerging data types like long-read sequencing and single-cell genomics presents a product expansion opportunity.

Risk Factors

Intense competition from both large enterprise software providers and free, open-source platforms.

The core market shift from desktop to cloud-based bioinformatics solutions threatens its traditional business model.

Risk of innovation lag if development cannot keep pace with the rapidly advancing sequencing technology and computational biology fields.

Competitive Landscape

DNASTAR competes in a fragmented bioinformatics software market. Key competitors include large life science tools companies like Illumina (BaseSpace), Thermo Fisher Scientific (Partek Flow), and Qiagen; other desktop software providers like Geneious; and a wide array of open-source platforms and cloud-native startups (e.g., DNAnexus, Seven Bridges). Its competitive edge has historically been ease of use and integrated desktop functionality for specific applications.

More companies in Diagnostics & Precision Medicine →More companies in United States →